covid-19 vaccine

Moderna presents preliminary results of phase 1 clinical trials of its experimental vaccine, which could be effective and safe.

There are different ways of approaching the development of a vaccine, depending on its composition and operation. A complete document published by the journal 'Nature' reviews these types of protovaccines that are currently being tested to deal with COVID-19.

According to the WHO, there are 70 vaccines in development and three of them are being tested in humans. The rush can jeopardize the efficacy of the future vaccine.

The 'Nicotiana benthamiana', native to Australia and a close relative of the tobacco plant, could produce the antibody against COVID-19.

It uses a harmless virus as a vehicle to transport the spike proteins of MERS, another cousin coronavirus to the one that causes COVID-19.

A new prototype DNA vaccine to protect against SARS-CoV-2 is ready for human trials, which will begin in a few days.

In the southern hemisphere, the arrival of winter and the possible coincidence of SARS-CoV-2 with the influenza virus and the respiratory syncytial virus are worrisome.